DE69515340T2 - Impfstoff gegen mycobakterielle infektionen - Google Patents
Impfstoff gegen mycobakterielle infektionenInfo
- Publication number
- DE69515340T2 DE69515340T2 DE69515340T DE69515340T DE69515340T2 DE 69515340 T2 DE69515340 T2 DE 69515340T2 DE 69515340 T DE69515340 T DE 69515340T DE 69515340 T DE69515340 T DE 69515340T DE 69515340 T2 DE69515340 T2 DE 69515340T2
- Authority
- DE
- Germany
- Prior art keywords
- vaccine against
- mycobacterial infections
- coding sequence
- against mycobacterial
- mycobacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 108091026890 Coding region Proteins 0.000 abstract 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 abstract 1
- 206010024229 Leprosy Diseases 0.000 abstract 1
- 206010062207 Mycobacterial infection Diseases 0.000 abstract 1
- 101710201541 Proline-rich antigen Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4648—Bacterial antigens
- A61K39/464817—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9409985A GB9409985D0 (en) | 1994-05-18 | 1994-05-18 | Vaccine against mycobacterial infections |
PCT/GB1995/001119 WO1995031216A1 (en) | 1994-05-18 | 1995-05-18 | Vaccine against mycobacterial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69515340D1 DE69515340D1 (de) | 2000-04-06 |
DE69515340T2 true DE69515340T2 (de) | 2000-10-19 |
Family
ID=10755365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69515340T Expired - Fee Related DE69515340T2 (de) | 1994-05-18 | 1995-05-18 | Impfstoff gegen mycobakterielle infektionen |
Country Status (11)
Country | Link |
---|---|
US (2) | US6492145B1 (de) |
EP (1) | EP0804230B1 (de) |
JP (2) | JP4435870B2 (de) |
KR (1) | KR970703165A (de) |
AT (1) | ATE189961T1 (de) |
AU (1) | AU702162B2 (de) |
CA (1) | CA2190515C (de) |
DE (1) | DE69515340T2 (de) |
ES (1) | ES2146314T3 (de) |
GB (1) | GB9409985D0 (de) |
WO (1) | WO1995031216A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6338852B1 (en) | 1995-09-01 | 2002-01-15 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6290969B1 (en) * | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
GB9706078D0 (en) * | 1997-03-24 | 1997-05-14 | Chiron Spa | Screening method and proteins and dna identified thereby |
US6465633B1 (en) | 1998-12-24 | 2002-10-15 | Corixa Corporation | Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis |
US20040258672A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Graft acceptance through manipulation of thymic regeneration |
US20040259803A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Disease prevention by reactivation of the thymus |
US20050020524A1 (en) * | 1999-04-15 | 2005-01-27 | Monash University | Hematopoietic stem cell gene therapy |
US20070274946A1 (en) * | 1999-04-15 | 2007-11-29 | Norwood Immunoloty, Ltd. | Tolerance to Graft Prior to Thymic Reactivation |
US20040265285A1 (en) * | 1999-04-15 | 2004-12-30 | Monash University | Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
AUPR074500A0 (en) * | 2000-10-13 | 2000-11-09 | Monash University | Treatment of t cell disorders |
US20040241842A1 (en) * | 1999-04-15 | 2004-12-02 | Monash University | Stimulation of thymus for vaccination development |
US20060088512A1 (en) * | 2001-10-15 | 2006-04-27 | Monash University | Treatment of T cell disorders |
KR100992646B1 (ko) * | 2003-07-09 | 2010-11-05 | 제이에스알 가부시끼가이샤 | 파장판 |
US20080279812A1 (en) * | 2003-12-05 | 2008-11-13 | Norwood Immunology, Ltd. | Disease Prevention and Vaccination Prior to Thymic Reactivation |
US20070098735A1 (en) * | 2005-10-29 | 2007-05-03 | Chandawarkar Rajiv Y | Methods for the Elimination of Pathogens and Other Particulate Agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989012455A1 (en) * | 1988-06-15 | 1989-12-28 | Whitehead Institute For Biomedical Research | Stress proteins and uses therefor |
WO1990011092A1 (en) * | 1989-03-21 | 1990-10-04 | Vical, Inc. | Expression of exogenous polynucleotide sequences in a vertebrate |
JP5163646B2 (ja) * | 2007-07-19 | 2013-03-13 | パナソニック株式会社 | 画像表示装置 |
-
1994
- 1994-05-18 GB GB9409985A patent/GB9409985D0/en active Pending
-
1995
- 1995-05-18 AT AT95919492T patent/ATE189961T1/de not_active IP Right Cessation
- 1995-05-18 KR KR1019960706527A patent/KR970703165A/ko not_active Application Discontinuation
- 1995-05-18 DE DE69515340T patent/DE69515340T2/de not_active Expired - Fee Related
- 1995-05-18 AU AU25290/95A patent/AU702162B2/en not_active Ceased
- 1995-05-18 CA CA002190515A patent/CA2190515C/en not_active Expired - Fee Related
- 1995-05-18 EP EP95919492A patent/EP0804230B1/de not_active Expired - Lifetime
- 1995-05-18 ES ES95919492T patent/ES2146314T3/es not_active Expired - Lifetime
- 1995-05-18 US US08/737,487 patent/US6492145B1/en not_active Expired - Fee Related
- 1995-05-18 WO PCT/GB1995/001119 patent/WO1995031216A1/en active IP Right Grant
- 1995-05-18 JP JP52947295A patent/JP4435870B2/ja not_active Expired - Fee Related
-
2002
- 2002-08-23 US US10/226,935 patent/US20020198168A1/en not_active Abandoned
-
2007
- 2007-07-23 JP JP2007190620A patent/JP2007332149A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69515340D1 (de) | 2000-04-06 |
US6492145B1 (en) | 2002-12-10 |
WO1995031216A1 (en) | 1995-11-23 |
AU702162B2 (en) | 1999-02-18 |
EP0804230A1 (de) | 1997-11-05 |
AU2529095A (en) | 1995-12-05 |
JP4435870B2 (ja) | 2010-03-24 |
CA2190515C (en) | 2007-11-13 |
ATE189961T1 (de) | 2000-03-15 |
JP2007332149A (ja) | 2007-12-27 |
CA2190515A1 (en) | 1995-11-23 |
US20020198168A1 (en) | 2002-12-26 |
ES2146314T3 (es) | 2000-08-01 |
JPH10500128A (ja) | 1998-01-06 |
KR970703165A (ko) | 1997-07-03 |
GB9409985D0 (en) | 1994-07-06 |
EP0804230B1 (de) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69515340T2 (de) | Impfstoff gegen mycobakterielle infektionen | |
DE69734882D1 (de) | Dna immunisierung gegen chlamydia infektion | |
ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
BR9710968A (pt) | Antìgenos de célula b humana; reagentes correlatos | |
DE69333802T8 (de) | Äusseres membranprotein von haemophilus | |
DE69632536D1 (de) | Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren | |
ATE198754T1 (de) | Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung | |
ATE368052T1 (de) | Cd8 tuberkulose impfstoffe | |
BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
CY1109531T1 (el) | Πρωτεϊνες συντηξης του μυκοβακτηριδιου της φυματιωσης | |
DK0423302T3 (da) | Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner | |
FI791841A (fi) | Foerfarande foer framstaellning av utvalt protein | |
WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
NO20062315L (no) | Minimal DNA-sekvens som virker som en kromatinisolator og dets anvendelse i proteinekspresjon | |
ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
ES2146214T3 (es) | Vacunas para actinobacillus pleuropneumoniae. | |
KR910000177A (ko) | 가금 마이코플라즈마 항원 및 그 유전자를 함유한 재조합벡타, 및 그를 이용한 진단제 및 백신 | |
DE3884316D1 (de) | Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung. | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
ATE361363T1 (de) | Impfstoff, der peroxiredoxin enthält | |
SE9602822D0 (sv) | New receptor | |
AU1540795A (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
AU2667600A (en) | Identification of specific differentially expressed antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |